{
    "abstract": null,
    "authors": [
        {
            "affiliation": "Pharmacy Department, Dijon Bourgogne University Hospital, 14, rue Gaffarel, 21000 Dijon, France. Electronic address: mathieu.boulin@chu-dijon.fr.",
            "firstname": "Marylise",
            "initials": "M",
            "lastname": "Sterl\u00e9"
        },
        {
            "affiliation": "Pharmacy Department, Georges-Fran\u00e7ois-Leclerc Center, Inserm U1231, Dijon, France.",
            "firstname": "Antonin",
            "initials": "A",
            "lastname": "Schmitt"
        },
        {
            "affiliation": "Pharmacy Department, Dijon Bourgogne University Hospital, Inserm U1231, Dijon, France.",
            "firstname": "Mathieu",
            "initials": "M",
            "lastname": "Boulin"
        }
    ],
    "conclusions": null,
    "copyrights": null,
    "doi": "10.1016/j.pharma.2024.04.005",
    "journal": "Annales pharmaceutiques francaises",
    "keywords": [
        "Cancer",
        "Dangers",
        "Digoxin",
        "Digoxine",
        "Harms",
        "Interaction"
    ],
    "methods": null,
    "publication_date": "2024-04-25",
    "pubmed_id": "38657856",
    "results": null,
    "title": "The harms of inappropriate digoxin prescribing in cancer patients: A drug-drug interaction with posaconazole.",
    "xml": "<Element 'PubmedArticle' at 0x788503c32e80>"
}